Quick Answer
Zomedica Corp. reported Total Revenue of $32.03 million for the year ending 2025.
- Zomedica Corp. showed an increase of +17.4% in Total Revenue from 2024 to 2025.
- This data is from Zomedica Corp.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $14.0 thousand | Q2 2021: $16.0 thousand | Q3 2021: $23.0 thousand | Q1 2022: $3.75 million | Q2 2022: $4.25 million | Q3 2022: $4.78 million | Q1 2023: $5.48 million | Q2 2023: $6.02 million | Q3 2023: $6.35 million | Q1 2024: $6.26 million | Q2 2024: $6.13 million | Q3 2024: $7.00 million | Q1 2025: $6.50 million | Q2 2025: $6.96 million | Q3 2025: $8.10 million.
- Historical annual values: Fiscal year 2025: $32.03 million | Fiscal year 2024: $27.29 million | Fiscal year 2023: $25.19 million | Fiscal year 2022: $18.93 million | Fiscal year 2021: $4.13 million | Fiscal year 2020: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: